NCT04289480 - Safety and Effectiveness of ENTERPRISE 2 Device in the Endovascular Treatment of Intracranial Aneurysms | Biotech Hunter

Enrollment

164

Participants

Timeline

Start Date

July 30, 2020

Primary Completion Date

April 22, 2022

Study Completion Date

September 10, 2026

Conditions

Intracranial Aneurysm

Interventions

DEVICE

ENTERPRISE 2 device

The ENTERPRISE 2 Vascular Reconstruction Device is intended for use with occlusive devices in the treatment of intracranial aneurysms.

Trial Locations (10)

Beijing Anzhen Hospital, Capital Medical University, Beijing

Beijing Tiantan Hospital, Capital Medical University, Beijing

Shengjing Hospital of China Medical University, Shenyang

Nanjing Drum Tower Hospital, Nanjing

Zhejiang Hospital, Hangzhou

The first affiliated hospital of Nanchang university, Nanchang

Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan

The first affiliated hospital of Zhengzhou university, Zhengzhou

Zhujiang Hospital of Southern Medical University, Guangzhou

Huashan Hospital Shanghai Medical college, Fudan University, Shanghai